ArticleInternational journal of women's dermatology2019
New oral and topical approaches for the treatment of melasma.
Article in International journal of women's dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 121 citations in OpenAlex.
- Bionic intelligent responsive barbed microneedles synergistically remodel the microenvironment for the treatment of refractory pigmentation disorders (melasma).Materials today. Bio · 2026Article
- Global consensus on the management of melanin hyperpigmentation disorders.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026Review
- Correlation Between Improvements in Melasma Quality of Life (MELASQoL-INA) and Modified Melasma Area and Severity Index (mMASI) Following Triple Combination Therapy.Clinical, cosmetic and investigational dermatology · 2026Article
- Systematic Review and Meta-Analysis of Treatments on Melasma Area Severity Index and Quality of Life.Pharmaceutics · 2025Review
- The effects and safety of sequential high concentration glycolic acid and trichloroacetic acid chemical peels in skin photo-type IV-VI, a retrospective cross-sectional monocentric review.International journal of women's dermatology · 2025Article
- Decrypting the Potential of Lipidic Vesicular System for Delivery Enhancement of Tranexamic Acid in Melasma Hyperpigmentation Treatment.Advanced pharmaceutical bulletin · 2025Review
- Latin American consensus on the treatment of melasma.International journal of dermatology · 2025Review
- Successful Treatment of Recalcitrant Melasma with Picolaser and Isobionicamide-Cysteamine Combination.The Journal of clinical and aesthetic dermatology · 2025Article
- Uses of tranexamic acid and the risk of thrombosis in women: Number 11 - 2025.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025Article
- Fermented Fish Collagen Attenuates Melanogenesis via Decreasing UV-Induced Oxidative Stress.Marine drugs · 2024Article
- Article
- Management of Melasma: Laser and Other Therapies-Review Study.Journal of clinical medicine · 2024Review
- Carotenoids in red fruit (Biomedical reports · 2024Review
- Different therapeutic approaches in melasma: advances and limitations.Frontiers in pharmacology · 2024Review
- Article
- Melasma in people with darker skin types: a scoping review protocol on prevalence, treatment options for melasma and impact on quality of life.Systematic reviews · 2023Article
- Clinical Applications ofLife (Basel, Switzerland) · 2023Review
- Review
- Skin Pigmentation Types, Causes and Treatment-A Review.Molecules (Basel, Switzerland) · 2023Review
- Review on photoprotection: a clinician's guide to the ingredients, characteristics, adverse effects, and disease-specific benefits of chemical and physical sunscreen compounds.Archives of dermatological research · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melasma is a common, therapeutically challenging, and universally relapsing disorder of hyperpigmentation that is most often observed in women and individuals with Fitzpatrick Skin Types III through VI. The pathogenesis of melasma is complex and protean. Contributing factors that are often implicated in the etiopathogenesis of this condition include a genetic predisposition, intense ultraviolet radiation exposure, and hormonal influences. Therapeutic interventions for melasma include a multimodality approach incorporating photoprotection agents, topical and oral skin lighteners, and resurfacing procedures. Given our expanding knowledge of the pathogenesis of melasma, new and effective treatments are expanding our therapeutic armamentarium. This article reviews new and emerging oral and topical treatments for melasma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.